Xiao Li

发表

SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.

Yang Zhu, Xiao Li, Chun-kang Chang, 2016, Leukemia research.

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Saijuan Chen, Lanping Xu, Xiao Li, 2016, Tumor Biology.

The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Feng Xu, 2012, Medical Oncology.

Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2014, European journal of haematology.

Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes: Cytogenetic Characterization

Xiao Li, Chun-kang Chang, Qi He, 2012, Acta Haematologica.

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes

Xiao Li, Chun-kang Chang, Feng Xu, 2017, Scientific Reports.

Somatic mutations of activated signaling genes, transcription factors, or tumor suppressors are a precondition for leukemic transformation from myelodysplastic syndromes: a sequencing analysis of 64 paired samples

Xiao Li, Chun-kang Chang, Feng Xu, 2021, bioRxiv.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

Xiao Li, Chun-kang Chang, Feng Xu, 2020, Scientific Reports.

Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2016, Scientific Reports.

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome

Ling Wu, Yang Zhu, Xiao Li, 2014, Scientific Reports.

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2014, PloS one.

High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Feng Xu, 2013, Tumor Biology.

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34+ cells and predicts poor prognosis and distinct response to CHG chemotherapy or decitabine

Yan Zhang, Xiao Li, Chun-kang Chang, 2012, Annals of Hematology.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2021, Clinical Epigenetics.

Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway.

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, Oncotarget.

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Xiao Li, Chun-kang Chang, Juan Guo, 2017, American journal of translational research.

Somatic mutations in SF3B1 aberrant‐negative MDS‐RS most commonly involved in TP53 genes

Xiao Li, Juan Guo, Lingyun Wu, 2022, Journal of cellular and molecular medicine.

Low RPS14 expression in MDS without 5q ‐ aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non‐5q‐ patients

Xiao Li, Chun-kang Chang, Lingyun Wu, 2013, European journal of haematology.

Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS‐based immunophenotypes

Xiao Li, Chun-kang Chang, Lingyun Wu, 2010, British journal of haematology.

Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Interleukin‐17 enhances the production of interferon‐γ and tumour necrosis factor‐α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes

Yan Zhang, Xiao Li, Chun-kang Chang, 2013, European journal of haematology.

Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2013, Cytometry. Part B, Clinical cytometry.

Distinct Clinical and Experimental Characteristics in the Patients Younger than 60 Years Old with Myelodysplastic Syndromes

Z. Xiao, Xiao Li, Chun-kang Chang, 2013, PloS one.

Overexpression of BMI1 confers clonal cells resistance to apoptosis and contributes to adverse prognosis in myelodysplastic syndrome.

Xiao Li, Chun-kang Chang, Juan Guo, 2012, Cancer letters.

TP53 mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, British journal of haematology.

Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS

X. Zhang, Xiao Li, Chun-kang Chang, 2011, Journal of Cancer Research and Clinical Oncology.

Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Lingyun Wu, 2007, Leukemia & lymphoma.

Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia

Xiao Li, Chun-kang Chang, Lingyun Wu, 2012, Annals of Hematology.

Impaired osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with lower-risk myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2013, Tumor Biology.

Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.

Sida Zhao, Xiao Li, Chun-kang Chang, 2015, American journal of translational research.

Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).

Xiao Li, Chun-kang Chang, Lingyun Wu, 2010, Internal medicine.

A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).

Xiao Li, Chun-kang Chang, Lingyun Wu, 2009, Leukemia research.

Chidamide, a novel histone deacetylase inhibitor, inhibits the viability of MDS and AML cells by suppressing JAK2/STAT3 signaling.

Sida Zhao, Xiao Li, Chun-kang Chang, 2016, American journal of translational research.

Primary lymphoma of bone: a case report and review of the literature

Xiao Li, Chun-kang Chang, Lingyun Wu, 2011, Medical oncology.

Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, Hematology.

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Journal of Translational Medicine.

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome

Yang Zhu, Xiao Li, Chun-kang Chang, 2016, Oncotarget.

Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes

Xiao Li, Juan Guo, Lingyun Wu, 2022, Journal of cellular and molecular medicine.

Xenogeneic immunosuppression of human umbilical cord mesenchymal stem cells in a major histocompatibility complex‐mismatched allogeneic acute graft‐versus‐host disease murine model

H. Fan, Jie Yang, Xiao Li, 2011, European journal of haematology.

Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Lingyun Wu, 2009, Leukemia & lymphoma.

Simultaneous Demonstration of Clonal Chromosome Abnormalities and Apoptosis in Individual Marrow Cells in Myelodysplastic Syndrome

H. Deeg, E. Bryant, Xiao Li, 2004, International journal of hematology.

Genomic landscape of CD34+ hematopoietic cells in myelodysplastic syndrome and gene mutation profiles as prognostic markers

Xin Xu, Yang Shen, Yang Li, 2014, Proceedings of the National Academy of Sciences.

Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Lingyun Wu, 2017, Scientific Reports.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

The role of histone methyltransferase EZH2 in myelodysplastic syndromes

Xiao Li, F. Xu, 2012, Expert review of hematology.

MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21

Xiao Li, Chun-kang Chang, Li Liu, 2017, Cell Death & Disease.

Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome

Xiao Li, Lingyun Wu, F. Xu, 2012, Journal of Cancer Research and Clinical Oncology.

[Yield of CD34(+) cells in graft can be increased significantly by G-CSF used at appropriate time after chemotherapy for AutoPBSCT].

Hong Liu, Xiao Li, Chun-kang Chang, 2011, Zhongguo shi yan xue ye xue za zhi.

IGF-IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2020, Oncology reports.

Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia

Xiao Li, Chun-kang Chang, Y. Tao, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Lingyun Wu, 2017, Scientific Reports.

Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring

Xiao Li, Chun-kang Chang, Lingyun Wu, 2011, Annals of Hematology.

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Downregulation of p21 in myelodysplastic syndrome is associated with p73 promoter hypermethylation and indicates poor prognosis.

Xiao Li, Chun-kang Chang, Juan Guo, 2013, American journal of clinical pathology.

Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Cytogenetic response based on revised IPSS cytogenetic risk stratification and minimal residual disease monitoring by FISH in MDS patients treated with low-dose decitabine.

Xiao Li, Chun-kang Chang, Lingyun Wu, 2013, Leukemia research.

The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine

Xiao Li, Chun-kang Chang, Y. Tao, 2019, Journal of Cancer Research and Clinical Oncology.

Decitabine of Reduced Dosage in Chinese Patients with Myelodysplastic Syndrome: A Retrospective Analysis

Q. Song, M. Hou, Xiao Li, 2014, PloS one.

Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells

M. Tanimoto, Jun Shi, E. Kondo, 2005, Cancer science.

Aberration of p73 promoter methylation in de novo myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2012, Hematology.

Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients

Xiao Li, Chun-kang Chang, Lingyun Wu, 2012, Hematology.

The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma

Xiao Li, Chun-kang Chang, Juan Guo, 2016, Hematology.

Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, Scientific Reports.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Wenhui Shi, 2016, Journal of Translational Medicine.

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes

Yuqian Zhu, Xiao Li, Chun-kang Chang, 2021, Cell Death & Disease.

SDF-1/CXCR4 signal is involved in decreased expression of p57kip2 in de novo MDS patients

Xiao Li, Chun-kang Chang, Juan Guo, 2012, Hematology.

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2017, Leukemia & lymphoma.

Cerebral venous and sinus thrombosis in a patient with acute promyelocytic leukemia during all-trans retinoic acid induction treatment.

Xiao Li, Chun-kang Chang, Lu-xi Song, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, OncoTarget.

Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR

Xiao Li, Chun-kang Chang, Wenhui Shi, 2015, PloS one.

Overexpression of IGF-IR in Malignant Clonal Cells in Bone Marrow of Myelodysplastic Syndromes

Xiao Li, Y. Tao, Yi-zhi Liu, 2010, Cancer investigation.

Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows

Xiao Li, Chun-kang Chang, Lingyun Wu, 2008, International journal of hematology.

Wilms' tumor gene (WT1) is predominantly expressed in clonal hematopoietic cells in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Lingyun Wu, 2007, Leukemia & lymphoma.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

Xiao Li, Chun-kang Chang, Juan Guo, 2020, Scientific Reports.

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes

Xiao Li, Juan Guo, Wenhui Shi, 2023, iScience.

Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Haematologica.

[Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].

Xiao Li, Chun-kang Chang, Lingyun Wu, 2009, Zhongguo shi yan xue ye xue za zhi.

Appropriate timing of G‐CSF use after mobilization chemotherapy significantly increases the yield of CD34+ cells in autoPBSCT

Xiao Li, Chun-kang Chang, Li Xu, 2009, Journal of clinical apheresis.

[Research advances of hepcidin expression and its regulation mechanism].

Xiao Li, Chun-kang Chang, C. Xiao, 2012, Zhongguo shi yan xue ye xue za zhi.

The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2013, Hematology.

Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome

Xiao Li, Chun-kang Chang, F. Xu, 2012, European journal of haematology.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Qi He, Feng Xu, Lingyun Wu, 2016, Journal of Translational Medicine.

The bcl6 corepressor mutation regulates the progression and transformation of myelodysplastic syndromes by repressing the autophagy flux.

Xiao Li, Chun-kang Chang, Juan Guo, 2023, The international journal of biochemistry & cell biology.

Efficacy and toxicity of decitabine versus CHG regimen (low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor) in patients with higher risk myelodysplastic syndrome: a retrospective study

Xiao Li, Chun-kang Chang, Lingyun Wu, 2016, Leukemia & lymphoma.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy

Xiao Li, Chun-kang Chang, Juan Guo, 2020, British Journal of Haematology.

[Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].

Xiao Li, Chun-kang Chang, Lingyun Wu, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.